Drugs / FMP30
last change Jun 2020 re-read 3 minutes ago

FMP30

Developed for
Sjogren syndrome
Investigated by
Microbiome Health Research Institute · Sjogrens Syndrome Foundation · University of Miami

Trials 1

2020202120222023202420252026
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 1 NCT03926286 Apr 2019 → Jun 2020 Sjogren syndrome University of Miami Completed No outcome recorded

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as FMP30 “FMP-30 containing frozen human fecal microbiota administered as (3) units of FMP30 enema on Day 0 and Week1” NCT03926286 ↗
1

NCT03926286 ↗

Route Rectal “administered as (3) units of FMP30 enema on Day 0 and Week1” NCT03926286 ↗